Skip to main content
. 2018 Feb 11;2018(2):CD001487. doi: 10.1002/14651858.CD001487.pub3

Summary of findings 3. Externally supported graft compared to unsupported graft for above‐knee femoro‐popliteal bypass surgery.

Externally supported graft compared to unsupported graft for above‐knee femoro‐popliteal bypass surgery
Patient or population: people with peripheral vascular disease requiring above‐knee femoro‐popliteal bypass surgery
 Setting: hospital
 Intervention: externally supported graft
 Comparison: unsupported graft
Outcomes Anticipated absolute effects* (95% CI) Relative effect
 (95% CI) № of limbs
 (studies) Quality of the evidence
 (GRADE) Comments
Risk with unsupported graft Risk with externally supported graft
Primary patency
(24 months)
Study population OR 2.08
 (1.29 to 3.35) 270
 (2 RCTs) ⊕⊕⊝⊝
 LOW 1 2 180 fewer unsupported prosthetic grafts per 1000 (61 to 293 grafts per 1000) lose primary patency by 24 months compared to externally supported prosthetic grafts
376 per 1000 556 per 1000
 (437 to 669)
Primary patency
(60 months)
No studies comparing supported and unsupported Dacron reported on primary patency at 60 months
Secondary patency
(24 months)
Study population OR 2.25
 (1.24 to 4.07) 236
 (1 RCT) ⊕⊕⊝⊝
 LOW 1 2 143 fewer unsupported Dacron grafts per 1000 (32 to 281 grafts per 1,000) lose secondary patency by 24 months compared to externally supported Dacron grafts
165 per 1000 308 per 1000
 (197 to 446)
Limb salvage No studies of these graft types reported on this outcome
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 
 CI: Confidence interval; OR: Odds ratio;
GRADE Working Group grades of evidenceHigh quality: We are very confident that the true effect lies close to that of the estimate of the effect
 Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
 Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
 Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 Downgraded because of serious risk of bias due to lack of blinding and poor randomisation techniques
 2 Downgraded due to imprecision because of the low number of participants and events